Showing results (2311-2320 of 6,740) with videos related to
Sort By:
Pageof 674
Oncotargets and Therapy|June 26, 2020
Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Cell Progression and Paclitaxel Resistance by Regulating miR-126-5p/ATAD2 AxisChang Liu, Jianfeng Hou, Fengxiao Shan, et al.Oncotargets and Therapy|June 26, 2020
Salinomycin and Sulforaphane Exerted Synergistic Antiproliferative and Proapoptotic Effects on Colorectal Cancer Cells by Inhibiting the PI3K/Akt Signaling Pathway in vitro and in vivoFang Liu, Rong-Bin Lv, Yan Liu, et al.Oncotargets and Therapy|June 26, 2020
lncRNA MT1JP Suppresses Biological Activities of Breast Cancer Cells in vitro and in vivo by Regulating the miRNA-214/RUNX3 AxisQianwen Ouyang, Yanru Cui, Shixin Yang, et al.Oncotargets and Therapy|March 26, 2013
Targeted treatment for advanced soft tissue sarcoma: profile of pazopanibRajeev Rajendra, Robin L Jones, Seth M PollackOncotargets and Therapy|March 26, 2013
Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinomaDan Wang, Jia-Xin Yang, Dong-Yan Cao, et al.Oncotargets and Therapy|March 26, 2013
Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signalingHeiying Jin, Wei Gong, Chunxia Zhang, et al.Oncotargets and Therapy|March 22, 2013
Antitumor activity of dichloroacetate on C6 glioma cell: in vitro and in vivo evaluationYu Duan, Xin Zhao, Wei Ren, et al.Oncotargets and Therapy|November 23, 2012
The impact of tumor size change after target therapy on survival: analysis of patients enrolled onto three clinical trials of advanced NSCLC from one institutionJianwei Zhang, Yan Huang, Xiaoling Li, et al.Oncotargets and Therapy|August 14, 2013
Update on oncolytic viral therapy - targeting angiogenesisJames R Tysome, Nick R Lemoine, Yaohe WangOncotargets and Therapy|August 17, 2013
Human epidermal growth factor receptor-2 overexpression and amplification in metastatic and recurrent high grade or type 2 endometrial carcinomasRina Kato, Kiyoshi Hasegawa, Risa Ishii, et al.Pageof 674